These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6405556)

  • 1. Isolation of coeliac active peptide fractions from gliadin.
    Wieser H; Belitz HD; Ashkenazi A; Idar D
    Z Lebensm Unters Forsch; 1983; 176(2):85-94. PubMed ID: 6405556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of different wheat gliadins in coeliac disease.
    Wieser H; Springer G; Belitz HD; Ashkenazi A; Idar D
    Z Lebensm Unters Forsch; 1982; 175(5):321-6. PubMed ID: 6758408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease.
    Cornell HJ; Maxwell RJ
    Clin Chim Acta; 1982 Aug; 123(3):311-9. PubMed ID: 6811164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The toxic fraction of gliadin digests in coeliac disease. Isolation by chromatography on Biogel P-10.
    Jos J; Charbonnier L; Mossé J; Olives JP; de Tand MF; Rey J
    Clin Chim Acta; 1982 Mar; 119(3):263-74. PubMed ID: 6802520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid composition of peptides remaining after in vitro digestion of a gliadin sub-fraction with duodenal mucosa from patients with coeliac disease.
    Cornell HJ
    Clin Chim Acta; 1988 Sep; 176(3):279-89. PubMed ID: 3180479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coeliac activity of the gliadin peptides CT-1 and CT-2.
    Wieser H; Belitz HD; Idar D; Ashkenazi A
    Z Lebensm Unters Forsch; 1986 Feb; 182(2):115-7. PubMed ID: 3705771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system.
    Martucci S; Fraser JS; Biagi F; Corazza GR; Ciclitira PJ; Ellis HJ
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1293-8. PubMed ID: 14624152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino-acid sequence of the coeliac active gliadin peptide B 3142.
    Wieser H; Belitz HD; Ashkenazi A
    Z Lebensm Unters Forsch; 1984 Nov; 179(5):371-6. PubMed ID: 6524078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the gliadin-derived peptides which are biologically active in coeliac disease.
    Cornell H; Wieser H; Belitz HD
    Clin Chim Acta; 1992 Dec; 213(1-3):37-50. PubMed ID: 1477986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
    De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V
    Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agglutinating activity of wheat gliadin peptide fractions in coeliac disease.
    De Vincenzi M; Dessi MR; Giovannini C; Maialetti F; Mancini E
    Toxicology; 1995 Jan; 96(1):29-35. PubMed ID: 7863509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.
    de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD
    Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of pure toxic peptides from a beta-gliadin subfraction using high-performance liquid chromatography.
    Jos J; de Tand MF; Arnaud-Battandier F; Boissel JP; Popineau Y; Wajcman H
    Clin Chim Acta; 1983 Oct; 134(1-2):189-98. PubMed ID: 6652909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro toxicity testing of alcohol-soluble proteins from diploid wheat Triticum monococcum in celiac disease.
    De Vincenzi M; Luchetti R; Giovannini C; Pogna NE; Saponaro C; Galterio G; Gasbarrini G
    J Biochem Toxicol; 1996; 11(6):313-8. PubMed ID: 9176743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of in vitro gamma-interferon production in coeliac disease as a response to gliadin peptides.
    Cornell HJ; Skerritt JH; Puy R; Javadpour M
    Biochim Biophys Acta; 1994 May; 1226(2):126-30. PubMed ID: 8204658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical testing of gliadin fractions in coeliac patients.
    Ciclitira PJ; Evans DJ; Fagg NL; Lennox ES; Dowling RH
    Clin Sci (Lond); 1984 Mar; 66(3):357-64. PubMed ID: 6692666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coeliac active peptides from gliadin: large-scale preparation and characterization.
    Wieser H; Belitz HD
    Z Lebensm Unters Forsch; 1992 Mar; 194(3):229-34. PubMed ID: 1519388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gliadin-derived peptides from bread and durum wheats on in vitro cultures of human cell lines. Implications for coeliac disease pathogenesis.
    Rocca E; Paganuzzi Stammati A; Zampaglioni F; Zucco F
    Toxicol Lett; 1983 May; 16(3-4):331-8. PubMed ID: 6857727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spelt wheat and celiac disease].
    Forssell F; Wieser H
    Z Lebensm Unters Forsch; 1995 Jul; 201(1):35-9. PubMed ID: 7571865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins.
    Howdle PD; Ciclitira PJ; Simpson FG; Losowsky MS
    Scand J Gastroenterol; 1984 Jan; 19(1):41-7. PubMed ID: 6710076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.